Detalhe da pesquisa
1.
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood.
Prostate
; 84(9): 850-865, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571290
2.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
3.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging
; 51(5): 1361-1370, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114616
4.
Quantification of [99Tc]TcO4- in urine by means of anion-exchange chromatography-aerosol desolvation nebulization-inductively coupled plasma-mass spectrometry.
Anal Bioanal Chem
; 416(11): 2849-2858, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289357
5.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
6.
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
Radiology
; 307(4): e222010, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070991
7.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246997
8.
Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions.
J Urol
; 208(6): 1203-1213, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001731
9.
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
BMC Cancer
; 22(1): 375, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395766
10.
Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography.
J Nucl Cardiol
; 29(6): 2988-2999, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750727
11.
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.
Eur J Nucl Med Mol Imaging
; 48(12): 4016-4027, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903926
12.
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis.
Eur J Nucl Med Mol Imaging
; 48(4): 1200-1210, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970216
13.
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.
Eur J Nucl Med Mol Imaging
; 48(12): 4067-4076, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031719
14.
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Eur J Nucl Med Mol Imaging
; 48(1): 113-122, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383093
15.
Efficacy of 90Y-Radioembolization in Metastatic Colorectal Cancer Depending on the Primary Tumor Side.
Dig Dis
; 39(4): 351-357, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33142291
16.
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis.
Eur J Nucl Med Mol Imaging
; 47(9): 2106-2112, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062682
17.
Incremental diagnostic value of [18F]tetrafluoroborate PET-CT compared to [131I]iodine scintigraphy in recurrent differentiated thyroid cancer.
Eur J Nucl Med Mol Imaging
; 47(11): 2639-2646, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32248325
18.
Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions.
Eur J Nucl Med Mol Imaging
; 47(1): 160-167, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628514
19.
68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.
Eur J Nucl Med Mol Imaging
; 47(3): 624-631, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31673789
20.
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia.
Eur J Nucl Med Mol Imaging
; 47(3): 642-651, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31865408